Gabapentin Tablet
Product Images NDC 50090-7715
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 50090-7715). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image (E4b713f1 A833 4fc7 8a0f 696077ddc280 02)
This is a description of a clinical trial design involving two periods: a titration period where participants receive gradually increasing doses of medication, and a fixed dose period lasting four weeks. The study includes a placebo group and a group receiving a high dose of Gabapentin at 3600 mg/day. The evaluation is conducted over multiple weeks.*
Image (E4b713f1 A833 4fc7 8a0f 696077ddc280 03)
This text provides information about a study on pain management, specifically comparing the effects of placebo, 1800 mg/day of Gabapentin, and 2400 mg/day of Gabapentin over a 3-week dose titration period followed by a 4-week fixed dose period. It mentions a baseline measurement and a mean pain score.*
Image (E4b713f1 A833 4fc7 8a0f 696077ddc280 04)
This text provides data on the proportion of responders in controlled post-herpetic neuralgia (PHN) studies. It compares the percentage of patients experiencing a 50% reduction in pain score after treatment with different dosages of gabapentin (GBP) versus placebo. Study 1 shows a 34% response rate for GBP 3600 and 52% for GBP 800, while Study 2 indicates response rates of 50% for GBP 800 and 64% for GBP 2400. The text also notes statistical significance with p-values provided.*
Image (E4b713f1 A833 4fc7 8a0f 696077ddc280 05)
Label Image (Lbl500907715)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.